中性粒细胞与淋巴细胞比值可作为重症 COVID-19 患者中中重度 ARDS 的预测生物标志物。

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.

Department of Critical Care Medicine, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan Province, China.

Crit Care. 2020 Jun 5;24(1):288. doi: 10.1186/s13054-020-03007-0.

ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered.

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.